Drug trial aims to ease common side effect for new moms after surgery
NCT ID NCT06837129
Summary
This study tested whether a drug called nalbuphine could prevent nausea and vomiting caused by pain medication given during spinal anesthesia for a planned C-section. Researchers enrolled 180 women having elective C-sections to see if receiving nalbuphine reduced these common side effects in the first 24 hours after surgery. The goal was to improve comfort and recovery for new mothers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Anesthesiology, Faculty of Medicine, Thammasat University
Pathum Thani, Changwat Pathum Thani, 12121, Thailand
-
Faculty of Medicine Thammasat University
Pathum Thani, Changwat Pathum Thani, 12121, Thailand
Conditions
Explore the condition pages connected to this study.